May. 12 at 9:58 PM
A lot of these names are being priced like “average growth stocks” when the fundamentals say otherwise.
👉Click to view @StockMomentumLab for timely updates amid the volatility.
Here’s how the tape looks when you strip out the noise and focus on valuation + cash flow power:
$ADBE — ~9.7x forward P/E, ~42% FCF margin. Premium SaaS cash machine trading like it’s ex-growth.
$JD — ~9.3x forward P/E, ~40% EPS growth. China consumer + logistics scale still not fully re-rated.
$META — ~22.2x forward P/E with ~
$81B cash pile. One of the strongest balance sheets in mega-cap tech.
$NVO — ~12.3x forward P/E, ~27% FCF margin. Structural healthcare demand + pricing power still underappreciated.
Market keeps rotating narratives, but the underlying earnings power here hasn’t changed — if anything, it’s accelerating. This is where valuation disconnects usually compress fast when sentiment flips.
